During the corresponding time, The Oncology Institute Inc recorded a revenue increase by 34.62 % year on year, sequentially revenue grew by 9.39 %. While revenue at the The Oncology Institute Inc 's corporate clients
The Oncology Institute Inc's Comment on Sales, Marketing and Customers
The company operates a hybrid model of captive and network oncology practices to provide services to patients. It aims to establish network adequacy for members of payors with capitated or value-based arrangements. Growth in provider and clinic capacity is pursued through practice acquisitions, de novo clinic construction, and the deployment of independent oncology clinics. Clinics generally consist of three to four providers and are organized geographically into pods. The company competes in the U.S. healthcare market alongside large and medium-sized local and national cancer care providers, including traditional oncology physician practices and specialty benefit managers. Competitors include American Oncology Network, Inc., U.S. Oncology Network, Inc., OneOncology, Inc., Evolent Health, Thyme Care, and OncoHealth. The company targets payors with capitated or value-based contracts and focuses on optimizing contract performance and risk management through its clinic network design and staffing.
In an era where efficiency and streamlined processes are more crucial than ever, Ascertain and The Oncology Institute have emerged as leaders in the integration of touchless AI automation for oncology administration. Their collaboration culminated in the rapid deployment of a cutting-edge prior authorization system, remarkably established in just eight weeks, which has led to a staggering 95% reduction in authorization workload.This innovative system promises to reshape the operational landscape for oncology practices, simplifying a traditionally cumbersome process that often bogged down healthcare providers and strained resources. Prior authorization an essential step in approving treatments and procedures ...
CERRITOS, Calif., - April 04, 2024 The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) have chosen to join forces with Healthly, a burgeoning healthcare company, to redefine cancer care accessibility and experience for patients in Southern California. Healthly boasts over 180 primary care physicians, a comprehensive range of support services, and a core philosophy centered on preventive medicine.This strategic alliance, effective from July 1, 2024, will enable TOI to provide its exceptional cancer care services to patients affiliated with Healthly s medical groups and associated physicians across the region. By leveraging TOI s vast network of oncology clinics and providers, the collaboration aim...
WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and OhioCERRITOS, Calif., Jan. 25, 2024 - WellBe Senior Medical, a healthcare company focused on managing the population health of polychronic Medicare Advantage patients, has announced its collaboration with leading cancer care provider, The Oncology Institute, Inc. (NASDAQ: TOI). This partnership aims to enhance WellBe s cancer care capabilities and expand its services across Illinois and Ohio.WellBe Senior Medical is dedicated to providing comprehensive medical care for seniors, particularly those with multiple chronic conditions. By partnering with The Oncology Institute, they aim to exten...
The Oncology Institute Inc’s Comment on Sales, Marketing and Customers
The company operates a hybrid model of captive and network oncology practices to provide services to patients. It aims to establish network adequacy for members of payors with capitated or value-based arrangements. Growth in provider and clinic capacity is pursued through practice acquisitions, de novo clinic construction, and the deployment of independent oncology clinics. Clinics generally consist of three to four providers and are organized geographically into pods. The company competes in the U.S. healthcare market alongside large and medium-sized local and national cancer care providers, including traditional oncology physician practices and specialty benefit managers. Competitors include American Oncology Network, Inc., U.S. Oncology Network, Inc., OneOncology, Inc., Evolent Health, Thyme Care, and OncoHealth. The company targets payors with capitated or value-based contracts and focuses on optimizing contract performance and risk management through its clinic network design and staffing.
Sources:
The Oncology Institute Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: The Oncology Institute Inc’s corporate clients.
For your research, we’ve provided 9 tables on The Oncology Institute Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
73.11 %